Related Experiment Video
Updated: Jun 21, 2026
06:26
Analysis of Side Population in Solid Tumor Cell Lines
Published on: February 23, 2021
Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method
Murielle Mimeault1, Surinder K Batra
1Department of Biochemistry and Molecular Biology, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Methods in Molecular Biology (Clifton, N.J.)
|July 8, 2009
Summary
Cancer stem cells drive tumor growth, metastasis, and relapse. This study characterizes prostatic stem cells to develop better models and identify therapeutic targets for prostate cancer.
Area of Science:
- Oncology
- Stem Cell Biology
- Molecular Biology
Background:
- Cancer stem cells (CSCs) are implicated in tumor growth, metastasis, treatment resistance, and recurrence.
- The molecular events driving CSC transformation and their role in cancer progression are not fully understood.
- Understanding CSCs is crucial for developing effective cancer therapies.
Purpose of the Study:
- To characterize nonmalignant and malignant prostatic stem/progenitor cells.
- To establish improved in vitro and in vivo models of prostate cancer stem cells.
- To identify novel biomarkers and molecular targets for prostate cancer diagnosis and treatment.
Main Methods:
- Utilized the Hoechst side population method for CSC characterization.
- Employed well-established cell lines for prostatic stem/progenitor cell studies.
- Focused on mimicking genetic and phenotypic changes during prostate carcinogenesis.
Main Results:
- Successfully characterized prostatic stem/progenitor cells using the Hoechst side population technique.
- Developed a novel approach for creating more accurate CSC models.
- Laid the groundwork for identifying CSC-specific biomarkers and therapeutic targets.
Conclusions:
- The Hoechst side population method aids in characterizing CSCs.
- Novel CSC models can better represent prostate cancer progression.
- Identifying CSC-specific targets offers potential for improved diagnostics and therapeutics.
